Log in
Enquire now
‌

US Patent 12129297 Antibodies against TIM3 and uses thereof

Patent 12129297 was granted and assigned to Bristol-Myers Squibb Company on October, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
0
Date Filed
January 11, 2019
0
Date of Patent
October 29, 2024
0
Patent Applicant
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
0
Patent Application Number
16961545
0
Patent Citations
‌
US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
0
‌
US Patent 8101720 Immunoglobulin insertions, deletions and substitutions
0
‌
US Patent 8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture
0
‌
US Patent 10421807 Interleukin-31 monoclonal antibody
0
‌
US Patent 9334331 Bispecific antibodies
0
‌
US Patent 6989452 Disulfide prodrugs and linkers and stabilizers useful therefor
0
‌
US Patent 7087600 Peptidyl prodrugs and linkers and stabilizers useful therefor
0
‌
US Patent 7129261 Cytotoxic agents
0
‌
US Patent 7317091 Optimized Fc variants
0
‌
US Patent 7635757 B7-4 Antibodies and uses therefor
0
Patent Inventor Names
Christine Bee
0
Michelle Kuhne
0
Andy X. Deng
0
Brigitte Devaux
0
Huiming Li
0
Richard Yu-Cheng Huang
0
Mark J. Selby
0
Hong-An Truong
0
Ekaterina Deyanova
0
Guodong Chen
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12129297
0
Patent Primary Examiner
‌
Michael Allen
0
CPC Code
‌
A61K 39/39541
0
‌
C07K 16/00
0

Find more entities like US Patent 12129297 Antibodies against TIM3 and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.